Evidation, a leader in measuring and enhancing everyday health, has announced a long-term partnership with 1upHealth, a top provider of FHIR® platform solutions for claims and clinical data interoperability. This collaboration aims to advance patient-centered real-world health research by facilitating…
DIA, a global non-profit organization for life sciences professionals, will host discussions on Canada’s precision regulation initiatives, the enhancement of its clinical trial infrastructure, and international collaboration at the Canada Annual Meeting on November 14-15 in Gatineau, Quebec. Health Canada…
Palomar Health, a prominent healthcare system in North San Diego County, CA, has formed a multi-year partnership with IKS Health, a provider of technology-enabled healthcare solutions. This collaboration aims to harness advanced technology, including Gen AI, to support Palomar Health…
Nordic Pharma, Inc., a subsidiary of Nordic Group BV, introduced LACRIFILL Canalicular Gel, an innovative therapy for dry eye, in the U.S. this April and is showcasing it to leading ophthalmologists at AAO 2024. This cross-linked hyaluronic acid gel, approved…
Tasso, Inc., a leader in patient-centric blood collection solutions, recently surveyed over 600 U.S. adults aged 18 and older to explore their experiences and preferences regarding blood testing. The survey, titled Patient Preferences, Perceptions, and the Evolving Challenges of Ensuring…
Luminate Health, a leader in healthcare technology for the clinical laboratory and diagnostics sector, is achieving remarkable success with its Direct-to-Consumer (DTC) lab testing platform. This innovative service allows commercial and hospital laboratories to connect directly with patients, enhancing accessibility…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, recently shared encouraging outcomes from its Phase 2b/3 clinical trial (MK-1654-004) of clesrovimab, a monoclonal antibody aimed at preventing respiratory syncytial virus (RSV) in infants. The findings were presented…
Prolucent®, a leading provider of healthcare workforce optimization software and services, has announced a strategic investment from Northwell Holdings, the for-profit investment arm of Northwell Health, New York’s largest healthcare provider and private employer. This extended Series A funding follows…
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on innovative therapies for glaucoma, corneal disorders, and retinal diseases, has announced positive results from the second Phase 3 confirmatory trial for Epioxa™ (Epi-on). This next-generation corneal cross-linking…
Caracal Products & Services and I2Pure have announced a collaboration to introduce new cutting-edge disinfection and antimicrobial products. Caracal, a certified Minority Business Enterprise and Tier 1 diversity spend supplier, provides a wide range of quality products and value-added services…
PursueCare, a leader in virtual addiction treatment, has announced the launch of RESET® and RESET-O®, the first FDA-authorized prescription digital therapeutics for substance use disorder (SUD) and opioid use disorder (OUD). These innovative app-based therapies offer a self-guided 12-week cognitive…
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has announced that Health Canada has granted marketing authorization for DAYBUE™ (trofinetide) to treat Rett syndrome in patients aged two and older. This approval, under the Priority Review process, makes DAYBUE the first and only…